In-depth analysis of biotech, pharma, and the life sciencesIn-depth analysis of biotech, pharma, and the life sciencesep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues away from her effort to improve representation in clinical trials.“It’s been a little tough on the other side of the aisle,” Kelly said at a recent . “I don’t want to put one broad brush on everybody, but … they feel like the government’s putting their nose in something a little bit too much.”Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!This name...…In-depth analysis of biotech, pharma, and the life sciencesIn-depth analysis of biotech, pharma, and the life sciencesep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues away from her effort to improve representation in clinical trials.“It’s been a little tough on the other side of the aisle,” Kelly said at a recent . “I don’t want to put one broad brush on everybody, but … they feel like the government’s putting their nose in something a little bit too much.”Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!This name...WW…